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METHODOLOGY
Application of dual reading domains 
as novel reagents in chromatin biology reveals 
a new H3K9me3 and H3K36me2/3 bivalent 
chromatin state
Rebekka Mauser1†, Goran Kungulovski1†, Corinna Keup1, Richard Reinhardt2 and Albert Jeltsch1* 
Abstract 
Background: Histone post-translational modifications (PTMs) play central roles in chromatin-templated processes. 
Combinations of two or more histone PTMs form unique interfaces for readout and recruitment of chromatin interact-
ing complexes, but the genome-wide mapping of coexisting histone PTMs remains an experimentally difficult task.
Results:  We introduce here a novel type of affinity reagents consisting of two fused recombinant histone modifica-
tion interacting domains (HiMIDs) for direct detection of doubly modified chromatin. To develop the method, we 
fused the MPP8 chromodomain and DNMT3A PWWP domain which have a binding specificity for H3K9me3 and 
H3K36me2/3, respectively. We validate the novel reagent biochemically and in ChIP applications and show its specific 
interaction with H3K9me3–H3K36me2/3 doubly modified chromatin. Modification specificity was confirmed using 
mutant double-HiMIDs with inactivated methyllysine binding pockets. Using this novel tool, we mapped coexisting 
H3K9me3–H3K36me2/3 marks in human cells by chromatin interacting domain precipitation (CIDOP). CIDOP-seq 
data were validated by qPCR, sequential CIDOP/ChIP and by comparison with CIDOP- and ChIP-seq data obtained 
with single modification readers and antibodies. The genome-wide distribution of H3K9me3–H3K36me2/3 indicates 
that it represents a novel bivalent chromatin state, which is enriched in weakly transcribed chromatin segments and 
at ZNF274 and SetDB1 binding sites.
Conclusions: The application of double-HiMIDs allows the single-step study of co-occurrence and distribution of 
combinatorial chromatin marks. Our discovery of a novel H3K9me3–H3K36me2/3 bivalent chromatin state illustrates 
the power of this approach, and it will stimulate numerous follow-up studies on its biological functions.
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Background
The fundamental organizational unit of the eukary-
otic genome is the nucleosome, which consists of 147 
base pairs of DNA wrapped around a histone octamer 
containing two copies of the histone proteins H3, H4, 
H2A and H2B. The core histone proteins project out 
unstructured N-terminal tails, which are subject to more 
than a hundred post-translational modifications (PTMs) 
[1, 2]. These histone modifications have instructive roles 
and directly modulate numerous chromatin-templated 
processes such as gene expression, DNA replication and 
repair, as well as normal development and disease [3–5]. 
The biological effects of histone PTMs are predominantly 
mediated by a large variety of so-called reading domains, 
which specifically interact with modified histone proteins 
[6, 7]. Ever since the initial proposal of the histone code 
hypothesis [8, 9], much of the effort in chromatin biol-
ogy has been focused on the identification and mapping 
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of histone PTMs, aiming to understand their functional 
roles. However, the high number of different histone 
PTMs raises the question of whether defined combina-
tions of histone PTMs (either on the same tail or within 
the same nucleosome) carry specific biological mean-
ings beyond the roles of the individual marks [10]. This 
hypothesis is supported by the fact that many if not all 
chromatin interacting proteins and complexes bear mul-
tiple different binding modules each of them specific for 
individual PTMs, which allows for combinatorial readout 
[11–13]. Additionally, chromatin mapping approaches 
based on correlation and co-occurrence of individual 
histone PTMs suggested the presence of chromatin 
states characterized by specific PTM patterns, which 
are associated with unique functionalities [14, 15]; one 
example representing the intensively studied H3K4me3–
H3K27me3 bivalent state found in ES cells [16, 17].
However, the investigation of the physical co-
occurrence of individual histone PTMs on the same 
histone protein or nucleosome is an experimentally 
difficult task [13, 18]. The co-occurrence of two or 
more histone PTMs on a single histone protein can 
be best studied by top-down or middle-down mass 
spectrometry [6, 19], but this method cannot detect 
potential co-occurrence of modifications on differ-
ent histone tails and it does not allow for association 
of a particular histone modification with its under-
lying DNA sequence. Genome mapping of histone 
PTMs conventionally is conducted by chromatin 
immunoprecipitation (ChIP) coupled with quantita-
tive PCR (ChIP-qPCR) or massively parallel sequenc-
ing (ChIP-seq) using histone PTM-specific antibodies 
(Fig.  1a). Although such ChIP experiments have made 
an unparalleled contribution to deciphering the roles 
of individual histone marks in many nuclear processes, 
their application in studying the direct coexistence of 
two or more histone marks has been less straightfor-
ward. The reason for this is the high amount of mate-
rial necessary for two consecutive ChIPs (re-ChIP) and 
the low amount of recovered DNA, which complicates 
the preparation of libraries with high quality and com-
plexity suitable for deep sequencing. As a consequence, 
the vast majority of re-ChIP experiments of histone 
PTMs so far have been limited to downstream analysis 
by end-point PCR or quantitative PCR. Most impor-
tantly, in conventional ChIP experiments, it remains 
unclear whether an overlap of individual histone PTMs 
is due to a true physical coexistence of both marks on 
one nucleosome or whether they occur separately on 
adjacent nucleosomes. Moreover, the detection of two 
marks at one genomic region can be caused by differ-
ent modification states in different alleles (one allele 
Fig. 1 Concepts of this work. a Comparison of the novel approach of combined readout of two chromatin marks by double-HiMIDs with the 
conventional approach of ChIP/re-ChIP, which due to the two consecutive pull-downs typically suffers from low yield. b Schematic representation 
of the procedure of chromatin interacting domain precipitation (CIDOP) experiments using HiMIDs
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carrying mark 1 and the second mark 2) or in different 
cells of a heterogeneous biological sample. To compli-
cate things further, it is difficult to distinguish, whether 
observed overlaps of histone PTMs merely occur by 
chance or whether they have specific downstream 
effects and define unique bivalent (or multivalent) 
chromatin states. For this, an analysis of the genome-
wide distribution of the doubly modified chromatin is 
necessary; in case of a coincidental co-occurrence, the 
distribution is expected to reflect the intersection of 
the distribution of the individual marks, while a distri-
bution showing enrichments in specific target regions 
can be taken as an indication of a potential functional 
meaning of the signal.
Methylations of the H3 tail at K9 and K36 are exten-
sively studied and highly conserved histone PTMs. The 
trimethylation of H3K9 is a hallmark of facultative and 
constitutive heterochromatin in almost all eukaryotes 
[20–23], but it is also enriched in silenced genes [24]. By 
recruitment of reading domains such as the HP1 family 
members, this modification is involved in gene repres-
sion and heterochromatin formation [20]. It is mainly 
introduced by the SUV39H1, SUV39H2 and SETDB1 
enzymes [23], which are essential for embryonic devel-
opment, heterochromatin formation and gene silencing. 
H3K36 methylation can be introduced by different pro-
tein lysine methyltransferases (PKMTs), but H3K36me3 
is exclusively deposited by the SETD2 enzyme, which is 
targeted by binding to the CTD of the elongating RNAPII 
[20, 25]. Hence, it follows a gradient of enrichment, start-
ing from the 5′ ends of genes and peaking at their 3′ ends, 
which is correlated with expression. H3K36me2/3 has a 
role in the maintenance of repressed chromatin in tran-
scribed regions by recruitment of histone deacetylases 
[26, 27], H3K4 demethylase LSD2 [28], chromatin remod-
elers [29] and DNA methylation via the PWWP domain 
of DNMT3 enzymes [30, 31]. Moreover, the localization 
of both H3K9me3 and H3K36me2/3 in gene bodies has 
been associated with alternative splicing [32, 33] and both 
were found to co-occur frequently in mass spectromet-
ric studies. For example, one study found that about one 
quarter of H3K9me3 occurs together with H3K36me2/3 
on the same H3 tail and, conversely, about one-third of all 
H3K36me2/3 is paired with H3K9me3 [34] (Additional 
file 1: Figure S1). In ChIP-seq studies, regions containing 
H3K9me3 and H3K36me3 dual marks were identified at 
the 3′ exons of zinc finger (ZNF) genes on chromosome 
19 [35] which were later shown to bind ATRX as well [36].
Recently, we have applied recombinant histone modi-
fication interacting domains (HiMIDs) as an alternative 
to histone PTM antibodies in many chromatin biology 
experiments [37, 38]. Following rigorous quality con-
trol criteria, we have shown that selected recombinant 
HiMIDs perform at least as good as ENCODE validated 
antibodies [37, 38]. Inspired by the demand for novel rea-
gents necessary for functional analysis of combinatorial 
chromatin marks, we now extend the HiMID technol-
ogy by generating artificial double-HiMIDs comprising 
two well-characterized HiMIDs, fused together in order 
to exert a combined readout of two histone modifica-
tions at the same time in a standard chromatin precipi-
tation experiment (Fig.  1b). Using these novel reagents, 
we performed ChIP-like experiments, called CIDOP 
(chromatin interacting domain precipitation) using 
mononucleosomes prepared from human cells. Doubly 
modified mononucleosomes were precipitated with the 
recombinant double-HiMID, and the recovered DNA 
was analyzed by qPCR and next-generation sequencing. 
Our data show that properly designed double-HiMIDs 
enable readout of the coexistence of two histone marks 
on the same nucleosome. Afterward, we have success-
fully applied a recombinant double-HiMID designed 
to bind to H3K9me3 and H3K36me2/3 and discovered 
that co-occurrence of these two marks defines a new 
bivalent chromatin state with a distribution that clearly 
differs from the intersection of the distribution of both 
individual marks. Our results show that the H3K9me3–
H3K36me2/3 state is associated with the bodies of 
weakly transcribed genes and enhancers, especially of 
genes involved in cell cycle regulation and metabolism. 
In addition, we found that it is associated with the zinc 
finger–Trim28–SetDB1 pathway. Our new reagent allows 
the direct readout and mapping of two histone modifica-
tions physically co-occurring on the same nucleosome, 
opening the doors for future studies of complex signa-
tures in the histone code.
Methods
Cloning, site‑directed mutagenesis, expression 
and purification
The sequences encoding the PWWP domain of murine 
DNMT3A (279–420 of NP_001258682) and the chromo 
domain of MPP8 (also known as MPHOSPH8) (57–111 
of NP_059990.2) were amplified from existing plas-
mids [37] and cloned as GST-fusion proteins by Gibson 
assembly [39] into pGEX-6p-2 vector (GE Healthcare) or 
pMAL-c2X. Both domains were connected by a natural 
linker residing between the ADD and PWWP domain 
of DNMT3A (Additional file  1: Figure S6). The fusion 
proteins were overexpressed at 18–20 °C in LB medium, 
induced with 1  mM IPTG at 0.6–0.8  OD600 and puri-
fied by affinity chromatography as described [40]. The 
respective mutations (D329A in D3PWWP and F59A in 
M8Chromo) were introduced by site-directed mutagen-
esis [41] and validated by restriction analysis and Sanger 
sequencing.
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Peptide arrays and far‑western blot analyses
For far-western blot, native histones were isolated by acid 
extraction [42] from HEK293 cells. Recombinant histone 
H3 was purchased from New England Biolabs. Two and 
a half micrograms of native histones and one micro-
gram of recombinant histone H3 were electrophoresed 
on a 16–18% SDS-PA gel, transferred on a nitrocellulose 
membrane and incubated in blocking solution. The bind-
ing of recombinant domains to the nitrocellulose mem-
brane and the CelluSpots modified histone tail peptide 
arrays (Active Motif, Carlsbad, USA) was carried out as 
described in detail together with the bioinformatic analy-
ses [38, 43]. The full annotation of all spots is provided in 
Additional file 2: Table S6.
Antibodies
The following antibodies were used in this study: 
H3K9me3 (Abcam 8898, lot GR130967-1), H3K36me3 
(Abcam 9050, lot GR260274-1), H3K4me3 (Abcam 8580, 
lot GR85670-1) and H3K27me3 (Active Motif 39155, lot 
01613015). Validations of all antibodies are shown in [37, 
38].
Double peptide arrays
Different K9me3 and K36me3 modified and unmodified 
H3 (1–19) and H3 (26–44) peptides were synthesized 
by the SPOT method using Fmoc-based chemistry on 
a MultiPep RSi synthesizer (Intavis AG) and were pro-
cessed as described in detail previously yielding in solu-
tions of peptides covalently attached to cellulose [44, 45]. 
From these stock solutions, equal volumes of two pep-
tides were mixed and 50 nl of the mixture spotted with 
a robust pipetting system on a white-coated glass slide 
leading to a spot diameter of approximately 500 µm. The 
binding of the domains to the double peptide spots on 
the glass slide was tested according to standard western 
blotting protocols. For blocking, the glass slides were 
incubated in TTBS with 5% milk and washed two times 
with TTBS (10  mM Tris–HCl pH 7.5, 0.05% Tween-20, 
150  mM NaCl) and one time with interaction buffer 
(20  mM HEPES pH 7.5, 500  mM KCl, 1  mM EDTA, 
0,1 mM DTT, 10% glycerol). Then, the glass slides were 
incubated for 2  h at RT in 2  ml interaction buffer con-
taining 0.01  µM binding domains. Afterward, the glass 
slides were washed three times with TTBS and incu-
bated for 1 h at RT with anti-GST AB (1:5000 in TTBS, 
1% skim milk, GE Healthcare Life Science 27-4577-
01, lot 9541184). After washing three more times with 
TTBS, the glass slides were incubated for 1  h at RT 
with horseradish peroxidase conjugated anti-goat AB 
(1:5000 in TTBS, 1% skim milk, Sigma-Aldrich A4174, 
lot 071M4767). Finally, the glass slides were washed three 
times with TTBS and doused with ECL solution (Thermo 
Fisher Scientific). Images were captured with a FUSION 
advance solo 4 (PeqLab) under dynamic conditions and 
analyzed with ImageJ.
Chromatin precipitation (CIDOP) experiments
The basic CIDOP protocol follows published procedures 
[37, 38]. It comprises the following steps: preparation of 
mononucleosomes, pull-down using HiMIDs, isolation of 
DNA from precipitated nucleosomes and DNA analysis 
(Fig.  1b). Native mononucleosomes were isolated from 
HepG2 cells by micrococcal nuclease digestion of intact 
nuclei obtained as described [46]. Briefly, around 20 mil-
lion cells were resuspended in 5 ml TM 2 buffer (10 mM 
Tris–HCl pH7.4, 2  mM  MgCl2, 0.5  mM PMSF) supple-
mented with protease inhibitors (cOmplete ULTRA Tab-
lets, Mini, EDTA-free, Easy pack from Roche) and 150 µl 
of 20% NP-40 and incubated on ice for 5 min. The lysed 
cells were centrifuged at 1000 rcf for 10 min at 4 °C, and 
the pellet was washed again with TM2 buffer gently. After 
a second centrifugation step, the pellet containing the 
cell nuclei was resuspended in TM2 buffer (200–600  µl 
depending on the amount of pellet), filled in an Eppen-
dorf tube, pre-warmed at 37  °C and supplemented with 
1  mM  CaCl2. To obtain mononucleosomes, the nuclei 
were treated with 1.5  µl MNase (New England Biolabs 
M0247S) per 150 ng of DNA for 5–10 min at 37 °C with 
pipetting in between gently. The reaction was stopped 
with 2  mM EGTA. Then, 300  mM of NaCl was added 
and the sample was centrifuged at 13,000 rcf for 10 min 
at 4 °C. The supernatant containing the soluble mononu-
cleosomes was collected, snap frozen and kept at − 80 °C 
until further use.
For pre-clearing, 20  µl of glutathione Sepharose 
4B beads or Dynabeads Protein G (Invitrogen) were 
washed three times with 200  µl DP buffer and incu-
bated with 15–60 µg of the mononucleosomes (based on 
DNA absorbance) in a final volume of 500 µl DP buffer 
(16.7  mM Tris–HCl pH8, 167  mM NaCl, 1.1% Tri-
tonX-100, 1.2  mM EDTA) supplemented with protease 
inhibitors (cOmplete ULTRA Tablets, Mini, EDTA-free, 
Easy pack from Roche) for 1  h at +  4  °C with rotation. 
Afterward, the supernatant was transferred into a new 
tube and incubated with 0.5 µM of GST-tagged double-
HiMID, H3K9me3 antibody or H3K36me3 antibody 
overnight at + 4 °C with rotation. The next day, 20–40 µl 
of pre-washed glutathione Sepharose 4B beads or Dyna-
beads Protein G (Invitrogen) were added to the superna-
tant and incubated for 2 h at + 4 °C with rotation. Then, 
the beads were washed with CIDOP buffers [1  ×  1  ml 
low salt buffer (20 mM Tris–HCl pH 8, 150 mM NaCl, 1% 
Triton X-100, 2 mM EDTA, 0.1% SDS), 1 × 1 ml high salt 
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buffer (20  mM Tris–HCl pH 8, 500  mM NaCl, 1% Tri-
ton X-100, 2 mM EDTA, 0.1% SDS), 1 × 1 ml LiCl buffer 
(10 mM Tris–HCl pH 8, 250 mM LiCl, 1% Nonident-P40, 
1  mM EDTA, 1% sodium deoxycholate)] and 2  ×  1  ml 
TE buffer (10 mM Tris–HCl pH 8, 1 mM EDTA). In the 
experiments with the DNMT3A PWWP domain, the 
washing was carried out three times with 1  ml  PB200 
buffer (50  mM Tris–HCl, 200  mM NaCl, 1  mM EDTA, 
0.5% Nonidet P-40, 2 mM DTT) and twice with 1 ml TE 
buffer. Between each washing step, the beads were incu-
bated for 10 min at + 4 °C with rotation, spun down for 
2 min at 2000 rcf and the supernatant discarded.
The bound chromatin was eluted in 100  µl elution 
buffer (50  mM Tris–HCl, 50  mM NaCl, 1  mM EDTA, 
1% SDS) supplemented with 3  µl proteinase K (NEB # 
P8107S) for 45  min at room temperature with rotation 
and then incubated at + 55 °C for 60 min to improve the 
activity. The DNA was recovered using the Chromatin IP 
DNA Purification Kit from Active Motif.
Sequential CIDOP/ChIP
The coexistence of H3K9me3 and H3K36me3 was tested 
by sequential CIDOP/ChIP. For the first pull-down with 
the H3K9me3-specific M8Chromo HiMID, the CIDOP 
protocol was used as described above. After the last 
washing step, the HiMID bound complex was eluted 
with 200 µl DP buffer containing 40 mM reduced l-glu-
tathione (Applichem) for 2  h at 4  °C with rotation. The 
supernatant was transferred into a new tube, 20  µl was 
used for PCR analysis, and the rest was incubated with 
3 µl of H3K36me3 antibody overnight at +4 °C with rota-
tion. The next day, 40 µl of pre-washed Dynabeads Pro-
tein G (Invitrogen) was added to the supernatant and 
incubated for 2 h at + 4 °C with rotation. Then, the beads 
were washed with CIDOP buffers [1  ×  1  ml low salt 
buffer (20  mM Tris–HCl pH 8, 150  mM NaCl, 1% Tri-
ton X-100, 2 mM EDTA, 0.1% SDS), 1 × 1 ml high salt 
buffer (20  mM Tris–HCl pH 8, 500  mM NaCl, 1% Tri-
ton X-100, 2 mM EDTA, 0.1% SDS), 1 × 1 ml LiCl buffer 
(10 mM Tris–HCl pH 8, 250 mM LiCl, 1% Nonident-P40, 
1 mM EDTA, 1% sodium deoxycholate)] and twice with 
1  ml TE buffer (10  mM Tris–HCl pH 8, 1  mM EDTA). 
The bound chromatin was eluted in 100 µl elution buffer 
(50 mM Tris–HCl, 50 mM NaCl, 1 mM EDTA, 1% SDS) 
supplemented with 3 µl proteinase K (NEB # P8107S) for 
45 min at room temperature with rotation and then incu-
bated at + 55 °C for 60 min to improve the activity. The 
DNA was recovered using the Chromatin IP DNA Puri-
fication Kit (Active Motif ). The recovered DNA of both 
steps was analyzed by semiquantitative PCR with differ-
ent primers to detect the presence of the H3K9me3 and 
H3K36me3 marks.
qPCR analysis
The quantitative PCR assays were performed on a CFX96 
Real-Time detection system (Bio-Rad) using SsoFast 
EvaGreen supermix (Bio-Rad). A standard curve was 
generated to calculate the percent of precipitated DNA 
and test the efficiency of each primer set. The primer 
sequences are listed in Additional file  1: Tables S4, S5. 
Each sample was analyzed in 3 technical replicates. Bio-
logical repetition was conducted as indicated in the main 
text, and error margins were based on biological repeats.
CIDOP‑seq and ChIP‑seq
Before proceeding to Illumina sequencing on the 
HiSeq  2500 platform, the quality of DNA precipitation 
and library generation was checked with BioAnalyzer 
(Agilent Technologies, Santa Clara, USA). DNA frag-
ments <  200 bps corresponding to mononucleosomes 
were isolated from gel and used for library generation. 
Around 35–60 million, 100-nt sequence reads were 
obtained and mapped to hg38 with bowtie [47] within 
the Chipster or Galaxy platform [48, 49] retaining only 
uniquely mapped reads. Peaks were called with MACS 
[50] using the broad option  and using MACS2 within 
the Chipster platform. Peak intersection was determined 
using BEDtools [51]. Density profiles of normalized reads 
per kilobase per million (RPKM) were generated in Deep-
Tools [52] and visualized in the Integrative Genomics 
Viewer [53].
For definition of no H3K9me3 and/or H3K36me2/3, 
H3K9me3-only, H3K36me3-only and overlap of 
H3K36me3 and H3K9me3 chromatin states, the genome 
was divided into 1-kb or 3-kb bins and the number 
of normalized (to the highest dataset) reads per mil-
lion (RPM) was quantified using the SeqMonk software 
(http://www.bioinformatics.babraham.ac.uk/projects/
seqmonk/).
The distribution of genes per chromosome, peaks and 
overlap with chromatin segments was determined with 
EpiExplorer [54], and seqMINER was used for k-means 
clustering and heatmap generation [55]. The Spearman 
correlation of raw data in 10-kb bins and the metagene 
profiles were generated in DeepTools [52]. The GO anal-
ysis of clusters obtained by k-means clustering was car-
ried out in ChIP-Enrich [56]. P values for the gene sets 
were corrected for multiple testing using the Benjamini–
Hochberg false discovery rate approach. For GO analy-
ses, the first 10–15 categories termed “biological process” 
were selected.
The ChIP-seq datasets of H3K4me1, ZNF274, SetDB1 
and KAP1 (Trim28) were downloaded from ENCODE 
[57] and further mapped to Hg38 following our ChIP-
seq bioinformatics pipeline. The ZNF274, SetDB1 and 
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Trim28 peaks were downloaded from ENCODE and lift-
Overed to Hg38 [58].
RNA‑seq data analysis
For RNA-seq, available datasets from HepG2 cells [57] 
produced by Caltech were used:
wgEncodeCaltechRnaSeqHepg2R1x75dFastqRep1.
fastq.gz.
wgEncodeCaltechRnaSeqHepg2R1x75dFastqRep2.
fastq.gz.
The reads were mapped with TopHat from the Tuxedo 
Suite package [59] using default settings. The transcript 
assembly from both replicates was carried out in the 
RNA pipeline in SeqMonk, and the transcript list from 
both replicates was merged. All transcripts were ranked 
based on RPKM (reads per kilobase of exon per mil-
lion fragments mapped) and segregated in four groups 
based on their frequency distribution: no expression, low 
expression 1, low expression 2, medium expression, high 
expression.
Results
Recently, we have shown that the chromodomain from 
MPP8 (also known as MPHOSPH8) (M8Chromo) and 
the PWWP domain from DNMT3A (D3PWWP), which 
bind to H3K9me3 and H3K36me2/3, respectively, can 
be used as an alternative for histone PTM antibodies 
[37]. Previous studies have reported the co-occurrence 
of these marks (Additional file  1: Figure S1) suggesting 
the potential formation and functional role of the cor-
responding bivalent chromatin state. In order to directly 
study the coexistence of H3K9me3 and H3K36me2/3 
and map its genome-wide distribution, we sought to 
extend our HiMID technology, from the readout of sin-
gle histone PTMs to the readout of two modifications 
at the same time (Fig.  1). To achieve this, we fused the 
D3PWWP and the M8Chromo domains using a natural 
linker in the PWWP domain to generate a hybrid protein 
with N-terminal GST-tag (GST-D3PWWP-M8Chromo). 
By doing this, we hypothesized that the divalent interac-
tion with two histone PTMs of the hybrid double-HiMID 
will be stronger than the sum of the single monova-
lent interactions due to multidentate binding [11, 60], 
thus allowing for selective binding of doubly modified 
nucleosomes.
Dual readout of H3K36me2/3 and H3K9me3 leads 
to synergistic binding in vitro
To validate our reagent, first we employed CelluSpots 
modified histone tail peptide array profiling to con-
firm that the double-HiMID has retained the two spe-
cificities emanating from both individual domains. 
These arrays contain 384 histone peptides carrying 59 
post-translational modifications in different combi-
nations and can be used as cheap and efficient tool to 
analyze the specificity of histone peptide interaction of 
reading domains and antibodies [43, 61]. As expected, 
the D3PWWP-M8Chromo protein bound to peptides 
harboring H3K9me3, H3K27me3 and H3K36me2/3 
(Fig. 2a) [30, 37, 61]. The binding of H3K27me3 peptides 
by M8Chromo is a peptide binding artifact, which does 
not occur on full-length histones and nucleosomes [37]. 
As controls, two protein variants with inactivating bind-
ing pocket mutations in one of the domains were used: 
D3PWWP*-M8Chromo contained a D329A exchange in 
D3PWWP which inactivates K36me2/3 binding [30] and 
D3PWWP-M8Chromo* contained an F59A exchange 
in M8Chromo which inactivates K9me3 binding [37]. 
As expected, D3PWWP*-M8Chromo only bound to 
H3K9me3 and D3PWWP-M8Chromo* only bound to 
H3K36me2/3 (Additional file 1: Figure S2A). These data 
confirm that both domains in the dual reader recognize 
their cognate targets.
In order to further validate the specificity of the dual 
reader, we carried out far-western blot experiments 
with modified histones isolated from human cells and 
unmodified, recombinant histones. The D3PWWP-
M8Chromo (PM) protein and the corresponding binding 
pocket variants showed binding to native histones, but 
not to recombinant histones indicating that they recog-
nize only modified histones (Fig. 2b). In this experiment, 
the pull-down of native histones by the fully functional 
D3PWWP-M8Chromo was more efficient than that 
by the D3PWWP*-M8Chromo (P*M) or D3PWWP-
M8Chromo* (PM*) variants, which could be due to 
better binding of the double active hybrid domain to 
doubly modified histones or to binding of both types of 
single modified histones. The very weak binding of the 
D3PWWP-M8Chromo* protein which only carries an 
intact PWWP domain is in agreement with our previous 
findings [37] and with  Kd values determined for the pep-
tide binding of the isolated domains (M8Chromo 100–
200 nM [61, 62], D3PWWP 50–100 µM [30]).
Next, we compared the affinity of the D3PWWP-
M8Chromo and variant hybrid proteins in precipi-
tation experiments of mononucleosomes prepared 
from human cells (Additional file  1: Figure S2B) with 
stringent washing buffers, typically used in chroma-
tin immunoprecipitation (ChIP) or chromatin inter-
acting domain precipitation (CIDOP) experiments. 
Precipitated mononucleosomes were detected by west-
ern blot with anti-histone H3 antibody (Fig.  2c). While 
the D3PWWP*-M8Chromo domain showed a robust 
pull-down, the D3PWWP-M8Chromo* did not pull-
down nucleosomes under these conditions, because the 
PWWP is functional only under less stringent washing 
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conditions [37]. Interestingly, the D3PWWP-M8Chromo 
double-HiMID was more efficient in nucleosome pre-
cipitation than the D3PWWP*-M8Chromo domain 
(Fig. 2c). These results show that under stringent wash-
ing conditions, a larger amount of nucleosomes was pre-
cipitated by the D3PWWP-M8Chromo double domain 
than by the D3PWWP*-M8Chromo single reading 
domain, which can engage only in monovalent chro-
matin interactions. This observation suggests that the 
D3PWWP-M8Chromo double-HiMID binds doubly 
modified nucleosomes with higher affinity due to biva-
lent binding, which is particularly striking, as the amount 
of H3K9me3–H3K36me2/3 double modified mono-
nucleosomes in the input by definition must be smaller 
than the total amount of mononucleosomes carrying 
H3K9me3 regardless of the modification state of K36. 
To confirm that the double-HiMIDs retained the spe-
cificities of the single domains in CIDOP reactions as 
Fig. 2 The D3PWWP-M8Chromo double reading domain specifically interacts with native histones and nucleosomes. a Peptide array specificity 
profiling of the hybrid D3PWWP-M8Chromo recombinant protein. The peptide spots are annotated on the left side of the array, and the color code 
denotes the presence of the designated histone PTM in different combinations. The D3PWWP-M8Chromo domain displayed binding to H3K9me3, 
H3K27me3, H3K36me2 and H3K36me3 containing peptides. See also Additional file 1: Figure S2A and Additional file 2: Table S6. b Far-western blot 
analyses with D3PWWP-M8Chromo (PM) and its variants containing mutations in the M8Chromo (PM*) or D3PWWP (P*M) domains with native 
histones (NH) and recombinant histones (RH). The bar diagram shows a quantification of the data based on two repetitions. Error bars indicate 
the SEM. c Precipitation of mononucleosomes with D3PWWP-M8Chromo WT and its variants under stringent (CIDOP) washing conditions and 
detection with anti-H3 antibody. The Ponceau S staining represents a loading control of D3PWWP-M8Chromo and its variants. The bar diagram 
shows a quantification of the data based on two repetitions. Error bars indicate the SEM. See also Additional file 1: Figure S2B and C. d Specificity 
of the mononucleosomal CIDOP with D3PWWP-M8Chromo (PM) and its variants containing mutations in the M8Chromo (PM*) or D3PWWP (P*M) 
domains analyzed by western blot with the H3K9me3, H3K4me3 and H3K27me3 antibodies. 5% IN—5% input. See also Additional file 1: Figure S2
Page 8 of 19Mauser et al. Epigenetics & Chromatin  (2017) 10:45 
well, the mononucleosomal pull-down reactions were 
repeated and analyzed by western blot with H3K9me3 
and H3K36me3 antibodies for specific binding and with 
H3K4me3 and H3K27me3 antibodies detecting unrelated 
marks to assess specificity (Fig. 2d). As observed before, 
the D3PWWP-M8Chromo* double-HiMID did not show 
an efficient pull-down under these washing condition. As 
expected, the H3K9me3 and H3K36me3 modifications 
were detectable in the D3PWWP-M8Chromo pull-down, 
H3K9me3 also in the pull-down with the D3PWWP*-
M8Chromo double-HiMID. No signal was detectable 
with the H3K4me3 and H3K27me3 antibodies, demon-
strating the specificity of the CIDOP reaction. As before, 
the H3K9me3 and H3K36me3 signals of the intact dou-
ble domain were stronger than those of the mutated ver-
sions with only one active domain.
To investigate the combined interaction of the double-
HiMID with two modified peptides, we mixed H3 (1–19) 
and H3 (26–44) peptides with or without K9me3 or 
K36me3 modifications in all possible combinations and 
spotted the mixtures on a glass slide (Fig. 3a). The pres-
ence of the H3K9me3 and H3K36me3 marks was vali-
dated by antibody binding (Additional file 1: Figure S3). 
Afterward, the glass slides carrying the double peptide 
arrays were incubated under stringent high salt condi-
tions with the D3PWWP-M8Chromo double-HiMID 
and the corresponding binding pocket mutants (Fig. 3b). 
D3PWWP-M8Chromo showed a preference for binding 
to the peptide spot containing both modified peptides. In 
contrast, D3PWWP*-M8Chromo showed an equal bind-
ing to H3K9me3 peptides regardless of the modification 
state of K36 in H3 (26–44). The D3PWWP-M8Chromo* 
Fig. 3 Double peptide array experiments confirm bivalent binding of D3PWWP-M8Chromo to H3K9me3 and H3K36me3. a Schematic view of the 
double peptide arrays. Unmodified, K9me3 and K36me3 modified H3 (1–19) and H3 (26–44) peptides were mixed in all four possible combinations 
[(1) unmodified H3 (1–19) and unmodified H3 (26-44), (2) H3K9me3 modified H3 (1–19) and unmodified H3 (26–44), (3) unmodified H3 (1–19) and 
H3K36me3 modified H3 (26–44), and (4) H3K9me3 modified H3 (1–19) and H3K36me3 modified H3 (26–44)] and spotted on a glass slide. See also 
Additional file 1: Figure S3. b Binding of the D3PWWP-M8Chromo, D3PWWP*-M8Chromo and D3PWWP-M8Chromo* double-HiMIDS to the double 
peptide array. The array contains two replicates of the four spots. The bar diagrams show the quantification of the double array based on two repeti-
tions. Error bars indicate the SEM
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did not bind to the peptides under these conditions simi-
larly as observed before. These results clearly indicate 
that the double-HiMID can simultaneously interact with 
H3K9me3 and H3K36me3 modified peptides and this 
leads to an increased binding.
The interaction of D3PWWP-M8Chromo with double 
modified chromatin could be either based on the binding 
of two separate histone tails harboring H3K36me2/3 or 
H3K9me3 (in trans) or to the binding of one H3 tail con-
taining both H3K36me2/3 and H3K9me3 marks (in cis) 
or a combination of both. To discriminate these alterna-
tives, we investigated binding of D3PWWP-M8Chromo 
to recombinant H3-GST proteins consisting of the first 
60 amino acids of H3 containing trimethyllysine [63] 
analog at position 9 and position 36. The results of pull-
down studies with these substrates suggest an interac-
tion in trans (Additional file 3). However, this conclusion 
needs further validation using modified mononucleoso-
mal pull-downs because it is unclear whether trimethyl-
lysine analogs are fully efficient binding substrates for the 
respective HiMIDs and whether the modified H3-GST 
protein sufficiently mimics a nucleosome in this assay, 
which also contains DNA and provides additional protein 
binding interfaces.
CIDOP‑seq with double‑HiMID shows enrichment 
of bivalent H3K9me3–H3K36me2/3 modified chromatin
Since the above biochemical data showed that the dou-
ble-HiMID interacts with H3K36me3 and H3K9me3 
modified H3 tails, we were encouraged to investigate 
the application of the double-HiMID in chromatin 
interacting domain precipitation (CIDOP) experiments 
coupled with qPCR or NGS [37]. In principle, hybrid 
double domains can precipitate nucleosomes in two 
modes: either when any of the single or both marks are 
present (OR-logic) or only when both marks are pre-
sent at the same time (AND-logic). To discriminate 
between these modes of action in whole genome analy-
sis approaches, we carried out two CIDOP-seq experi-
ments with D3PWWP-M8Chromo and two experiments 
with D3PWWP*-M8Chromo, which has an inactivated 
PWWP domain (Fig.  4a). The D3PWWP-M8Chromo 
CIDOP-seq replicates were strongly correlated with 
one another, clustered together (Fig.  4b), and showed 
a large overlap of annotated peaks (Fig.  4c). Similarly, 
the D3PWWP*-M8Chromo repeats were highly corre-
lated and they clustered with the MPP8 Chromo single 
domain and anti-H3K9me3 antibody signals (Fig. 4b). As 
shown before, we were unable to carry out a successful 
CIDOP with D3PWWP-M8Chromo* under the wash-
ing conditions used here. Therefore, we used the previ-
ous DNMT3A PWWP CIDOP-seq data for all further 
comparative analyses [37] which were obtained under 
less stringent washing conditions. This dataset repre-
sented a third cluster (Fig.  4b) highly correlated with 
anti-H3K36me3 antibody signals validating its usage 
as marker for H3K36me2/3. All these three clusters 
(D3PWWP-M8Chromo, D3PWWP*-M8Chromo and 
D3PWWP) are only moderately correlated with each 
other, once more illustrating the clear difference in 
specificity between D3PWWP-M8Chromo and its con-
stituting single domains. Visual inspection of the data 
showed that strong D3PWWP-M8Chromo signals were 
present only in regions where individual H3K9me3 and 
H3K36me2/3 signals overlapped (Fig.  4a). In contrast, 
weaker D3PWWP-M8Chromo signals were observed in 
regions carrying only H3K36me2/3 or only H3K9me3 
signals. This result suggests that with an appropriate 
signal threshold the D3PWWP-M8Chromo double-
HiMID can be used as pull-down reagent to directly 
identify H3K9me3 and H3K36me2/3 doubly modified 
chromatin, in particular when used along with the cor-
responding single HiMIDs or domain inactive variants. 
To corroborate this conclusion, we binned the genome 
in 3-kb windows and defined four chromatin states based 
on the distribution of H3K9me3 (merged MPP8 Chromo 
and D3PWWP*-M8Chromo data) and H3K36me2/3 
(DNMT3A PWWP data): (1) without H3K9me3 and 
H3K36me2/3, (2) H3K36me2/3-only, (3) H3K9me3-
only and (4) overlap of H3K36me2/3 and H3K9me3 
(Fig.  4d). Interestingly, we observed a very strong 
enrichment of the bivalent H3K9me3–H3K36me2/3 
state in the D3PWWP-M8Chromo pull-down. While 
overall only 15% of all regions were assigned to the 
bivalent H3K9me3–H3K36me2/3 state, this fraction 
increased to 72% in the D3PWWP-M8Chromo pull-
down. We observed a 74% recovery of all H3K9me3–
H3K36me2/3 overlap regions, while the H3K9me3-only 
and H3K36me2/3-only regions were recovered much less 
efficiently (3 and 16%, respectively). Very similar conclu-
sions were drawn from an analysis using 1-kb bins and 
another analysis using more stringent signal thresholds 
(Additional file 1: Figure S4).
Next, we were interested to find out whether a more 
quantitative analysis of the CIDOP signals can discrimi-
nate between a model proposing the coexistence of both 
modifications at H3K9me3–H3K36me2/3 regions, as 
opposed to a model assuming a mixture of nucleosomes 
containing either H3K9me3 or H3K36me2/3 that could 
result from an inhomogeneous sample or allele-specific 
modification patterns. As first approach, we assumed 
that a mixture of nucleosomes carrying either H3K9me3 
or H3K36me2/3 should result in a lower overall signal for 
each individual mark in H3K9me3–H3K36me2/3 regions 
than a sample in which each nucleosome carries both 
marks. Therefore, we analyzed the average H3K9me3 
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Fig. 4 CIDOP-seq with the D3PWWP-M8Chromo double-HiMID. a Genome browser view of the CIDOP-seq signal from D3PWWP-M8Chromo and 
its variants. Note that strong D3PWWP-M8Chromo signal is only observed when DNMT3A PWWP and D3PWWP*-M8Chromo signals are present 
(black boxes). The green boxes denote examples of the presence of DNMT3A PWWP signal and the absence of D3PWWP*-M8Chromo signal. The 
red boxes denote examples the presence of D3PWWP*-M8Chromo signal and the absence of DNMT3A PWWP signal. b Heatmap of the Spearman 
correlation coefficients of raw read densities in 10-kb bins of D3PWWP-M8Chromo and D3PWWP*-M8Chromo CIDOP results with D3PWWP CIDOP 
and various antibody ChIP-seq data taken from Kungulovski et al. [37]. c Peak overlap between D3PWWP-M8Chromo replicates 1 and 2. d Analysis 
of chromatin states in HepG2 cells based on H3K9me3 and H3K36me2/3 CIDOP-seq signals using 3-kb bins. The red circle indicates the number of 
regions with H3K9me3 signal, the green circle indicates regions with H3K36me2/3 signal, and the blue circle indicates all regions. Red numbers refer 
to only H3K9me3 regions, green number to only H3K36me3 region, black numbers to regions with both signals, blue numbers to regions without 
both signals. The pull-down by D3PWWP-M8Chromo shows a strong and selective enrichment of the H3K9me3–H3K36me2/3 dual state. See also 
Additional file 1: Figure S4. e Average H3K9me3 and H3K36me2/3 signal intensity determined with the single reading domains at all H3K9me3 
regions, all H3K36me2/3 regions and regions carrying the H3K9me3–H3K36me2/3 double mark. In each case, the genome-wide average signal has 
been subtracted
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and H3K36me2/3 signal intensities (taken from the 
analysis of the single reader or antibodies) at H3K9me3–
H3K36me2/3 regions and compared them with the aver-
age signals at all H3K9me3 and all H3K36me2/3 regions 
(Fig. 4e). As expected, we found depletion of H3K9me3 at 
H3K36me3 regions and vice versa. However, we observed 
that the individual H3K9me3 signal at H3K9me3–
H3K36me2/3 regions is even stronger than the H3K9me3 
signal at all H3K9me3 regions. A similar finding was 
also made for H3K36me3. This result is not compatible 
with a model assuming that H3K9me3–H3K36me2/3 
regions represent a mixture of molecules only containing 
H3K9me3 or H3K36me3 single marks and is in favor of a 
model proposing the coexistence of both modifications.
A second strong experimental hint toward the pres-
ence of doubly marked chromatin is the enrichment of 
H3K36me3 containing nucleosomes by the D3PWWP-
M8Chromo double domain that was observed under 
stringent washing conditions. Under these conditions, 
no productive interaction of the single D3PWWP subdo-
main with nucleosomes was possible. Hence, it is likely 
that the mode of binding is the following: M8Chromo 
docks to H3K9me3 containing nucleosomes. The pres-
ence of H3K36me2/3, which is then bound by D3PWWP, 
enhances the binding affinity and leads to preference for 
doubly modified chromatin, rather than H3K9me3-only 
chromatin.
Validation of selected H3K9me3–H3K36me2/3 regions 
with quantitative CIDOP, ChiP and sequential CIDOP–ChIP
Twelve regions of different modification states were 
selected for further technical validation in independ-
ent CIDOP-qPCR and ChIP-qPCR experiments. 
Amplicons covering H3K36me2/3 and H3K9me3 
CIDOP-seq peak overlap regions were labeled as 
H3K9me3–H3K36me2/3, while singly modified regions 
were labeled as H3K36me2/3 or H3K9me3, respec-
tively. Our CIDOP-qPCR data showed binding of the 
D3PWWP-M8Chromo double domain to all H3K9me3 
and H3K36me2/3 regions. However, clear preferences 
for binding to H3K9me3–H3K36me3 doubly modi-
fied regions were observed. In contrast, the mutated 
D3PWWP*-M8Chromo protein bound to H3K9me3 
regions, not discriminating between the absence and 
presence of the second mark (Fig. 5a). The CIDOP with 
the D3PWWP-M8Chromo* protein (under less stringent 
conditions) was weak, but also showed preferences for 
H3K36me3 containing regions irrespective of the pres-
ence of H3K9me3. These results were highly reproducible 
in biological repetitions of this experiment. In addition, 
these regions were analyzed with anti-H3K9me3 and 
anti-H3K36me3 antibodies showing excellent agreement 
with the CIDOP-seq results. When combined, these data 
clearly show that strong D3PWWP-M8Chromo sig-
nals are indicative of the coexistence of H3K9me3 and 
H3K36me2/3, while weaker D3PWWP-M8Chromo sig-
nals indicate the presence of single modifications.
To further validate the presence of H3K9me3–
H3K36me2/3 doubly marked chromatin, we performed 
sequential CIDOP-ChIP, in which H3K9me3-specific 
M8Chromo CIDOP was followed by H3K36me3 ChIP 
using regions containing only H3K9me3, only H3K36me3 
or both marks. As shown in Fig.  5b, sequential pull-
down was only possible at doubly marked regions, con-
firming the coexistence of both marks at these sites. All 
these results clearly confirm that we indeed enriched 
nucleosomes carrying both marks and not a mixture of 
nucleosomes in which some carry H3K9me3 and others 
H3K36me2/3.
The H3K9me3–H3K36me2/3 bivalent state is enriched 
in weakly transcribed chromatin
All the data presented in the previous sections indicate 
that the hybrid affinity reagent made of the DNMT3A 
PWWP and MPP8 chromodomain specifically recog-
nize doubly modified nucleosomes. For that reason, from 
now on we refer to the D3PWWP-M8Chromo signal as 
bivalent H3K9me3–H3K36me2/3 state. Next, we wanted 
to investigate the distribution of nucleosomes with biva-
lent H3K9me3–H3K36me2/3 marks in HepG2 cells and 
check out whether it is non-random (i.e., enriched in 
defined functional elements), which would suggest that 
the bivalent H3K9me3–H3K36me2/3 modification rep-
resents a chromatin state with a biological role. To this 
end, we merged the peaks obtained from both CIDOP-
seq replicates (Fig. 4c) and used the EpiExplorer database 
[54] for initial data mining. By comparing the distribution 
of H3K9me3–H3K36me2/3 peaks and using the same 
number of randomized peaks as control, we observed an 
enrichment of H3K9me3–H3K36me2/3 in distinct chro-
matin states as defined by Ernst et  al. [15] (Additional 
file 1: Figure S5), all of them characterized by weak tran-
scription (Fig. 6a).
The H3K9me3–H3K36me2/3 bivalent state is enriched 
in weakly transcribed genes
To validate this observation, we plotted the H3K9me3–
H3K36me2/3, H3K9me3 and H3K36me2/3 signals over 
the promoters and bodies of all genes binned by their 
expression levels and observed a strong preference of the 
H3K9me3–H3K36me2/3 bivalent state for genes with 
low expression (green lines in Fig.  6b), while the distri-
bution of signal over highly expressed and non-expressed 
genes was similar to each other and lower than over lowly 
expressed genes (red and black lines). This was in sharp 
contrast to the individual H3K9me3 and H3K36me2/3 
Page 12 of 19Mauser et al. Epigenetics & Chromatin  (2017) 10:45 
signals indicating the distribution of H3K9me3–
H3K36me2/3 is distinct from the random intersection 
of both individual marks. As expected, H3K9me3 was 
highly enriched in non-expressed genes, but not in genes 
with high, medium and low expression, and H3K36me2/3 
was enriched in expressed genes (correlated with levels 
of expression), but not in non-expressed genes (Fig. 6b). 
To further dissect the chromatin state of genes with the 
lowest expression (low expression  2), we performed 
k-means clustering and re-affirmed that indeed several 
of the obtained clusters exhibit H3K9me3–H3K36me2/3 
enrichment (Fig.  6c). Comparison of the clusters con-
firmed that H3K9me3–H3K36me2/3 signal was only 
detected if both individual signals were present. The 
strongest H3K9me3–H3K36me2/3 signal was found in 
clusters 3, 5, 6, 7 and 9, which encode for gene ontol-
ogy (GO) categories associated with biological processes 
such as cell cycle transition, metabolism of nucleotides, 
morphogenesis and development (especially of bones) 
and hormone metabolism (Fig. 6d and Additional file 1: 
Table S1).
The H3K9me3–H3K36me2/3 bivalent state is enriched 
in particular subtypes of enhancers
In addition to “weak transcribed” chromatin segments 
and genes, we also observed an enrichment of the 
H3K9me3–H3K36me2/3 bivalent state in certain sub-
types of enhancers, decorated with H3K4me1 (Fig.  6a). 
Fig. 5 Additional validation of the detection of H3K9me3-H3K36me2/3 double modified chromatin. a Chromatin interacting domain precipita-
tion (CIDOP) and ChIP quantified by real-time PCR (qPCR). Twelve regions (Additional file 1: Table S4) containing only H3K9me3, only H3K36me3 
and both marks were selected. CIDOP was conducted with the D3PWWP-M8Chromo double domain and the two variants with one inactivated 
binding pocket D3PWWP-M8Chromo* (with inactivated H3K9me3 binding pocket) and D3PWWP*-M8Chromo (with inactivated H3K36me2/3 
binding pocket). In addition, ChIP experiments with H3K9me3 and H3K36me3 antibodies were performed to confirm the presence or absence of 
both marks. Each experiment was conducted in two biological replicates. Error bars show the SEM. b Sequential CIDOP-ChIP experiments were 
conducted on H3K9me3 only, H3K36me3 only and double mark regions. First, H3K9me3-specific M8Chromo CIDOP was conducted followed by 
H3K36me3 ChIP. The pull-down was analyzed by semiquantitative PCR
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Fig. 6 Association of the H3K9me3–H3K36me2/3 bivalent state with genomic states. a Overlap of the H3K9me3–H3K36me2/3 bivalent chromatin 
state with chromatin states defined by Ernst et al. [15]. b Metagene analyses of H3K9me3–H3K36me2/3, H3K9me3 and H3K36me2/3 distributions 
over gene bodies in relation to gene expression. c Clustering analysis of tag densities of H3K9me3–H3K36me2/3, H3K9me3, H3K36me2/3 and RNA 
pol II. Tags were collected in a 10-kb window (− 5 to + 5 kb) centered on the midpoints of TSS from genes with low expression 2 and sorted by 
k-means clustering (ten clusters). Five clusters with clear H3K9me3–H3K36me2/3 signal are annotated with red numbers. Other clusters not show-
ing strong H3K9me3–H3K36me2/3 signal are annotated with black numbers. The image also shows that the H3K9me3–H3K36me2/3 signal is only 
observed at regions with H3K9me3 and H3K36me2/3 signals confirming the double specificity of the pull-down. d Representative gene ontology 
(GO) analysis of biological processes linked with cluster 6. For more information about all the other clusters, refer to Additional file 1: Table S1
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To verify this observation, we selected H3K4me1 ChIP-
seq peaks associated with WE-1, WE-2, SE-1 and SE-2 
and plotted their H3K9me3–H3K36me2/3, H3K9me3 
and H3K36me3 signals (Fig. 7a). In agreement with our 
previous observations, we detected stronger enrichment 
of H3K9me3–H3K36me2/3 in WE-2 and SE-2 in com-
parison with WE-1 and SE-1, respectively. The stronger 
enrichment of bivalent marks in SE-2 compared to SE-1 
is in agreement with the selective enrichment of H3K9ac 
in SE-1 which competes with H3K9me3. The correspond-
ing single marks were enriched as well, which is in agree-
ment with a previous report [64]. To functionally dissect 
these two subtypes of enhancers, we performed k-means 
clustering, centered around the midpoints of H3K4me1 
peaks associated with WE-2 or SE-2, respectively, and 
found five clusters (out of ten) with high enrichment of 
H3K9me3–H3K36me2/3 in WE-2 and 3 clusters (out of 
ten) in SE-2 (Fig.  7b, c). Then, we linked the H3K4me1 
peaks from each cluster to the closest TSS in a distance 
of at least 10  kb (to associate enhancers with putative 
target genes but exclude promoters) and carried out GO 
analyses with these genes. The WE-2 enhancers (cluster 
4–8) were associated with genes involved in biological 
processes such as metabolism of xenobiotics, alcohols, 
vitamins, lipids and nucleotides, regulation of microtu-
bules, cell cycle and regulation of collagen (Fig.  7d and 
Additional file 1: Table S2). The SE-2 enhancers (clusters 
5–7) were associated with genes involved in biological 
processes such as regulation of protein localization and 
transport, skeletal, cartilage and connective tissue mor-
phogenesis and metabolism of xenobiotics, alcohols, 
lipids, vitamins and nucleotides (Fig.  7d and Additional 
file 1: Table S3).
The H3K9me3–H3K36me2/3 bivalent state is associated 
with the zinc finger–Trim28–SetDB1 pathway
So far, our data have indicated that the bivalent 
H3K9me3–H3K36me2/3 chromatin state is associated 
with weakly expressed genes, which are regulated in a cell 
type-dependent manner. Therefore, we were interested to 
investigate whether these regions contain binding sites 
for regulatory factors. We used the Re-Map database [65] 
to search for overlap of H3K9me3–H3K36me2/3 peaks 
with the binding sites of DNA-interacting factors in tens 
of cell types from hundreds of ChIP-seq experiments. 
Interestingly, we noticed a very significant overlap of the 
H3K9me3–H3K36me2/3 bivalent state with binding sites 
of ZNF274, Trim28, CBX3 and SetDB1, all of which are 
members of the zinc finger–Trim28–SetDB1 pathway 
(Fig.  8a). To explore this further, we searched for avail-
able ChIP-seq datasets of any of these proteins in HepG2 
cells and found one for ZNF274. ZNF274 peaks showed 
a striking correlation with H3K9me3–H3K36me2/3 
signal (Fig.  8b). These regions include ZNF genes on 
chromosome 19 which have already been described to 
contain H3K9me3–H3K36me3 marks clustered at the 
3′UTR exons [35]. The H3K9me3–H3K36me2/3 signal 
of representative regions was confirmed by independent 
CIDOP-qPCR experiments. Clustering of H3K9me3–
H3K36me2/3 and ZNF274 signals showed that over-
all around 60% of all ZNF274 sites are overlaid with 
H3K9me3–H3K36me2/3 in HepG2 cells (Fig.  8c). Since 
no SetDB1 and TRIM28 ChIP-seq datasets were available 
from HepG2 cells, we reasoned that some of their binding 
sites might be partially conserved between different cell 
lines and collected SetDB1 and TRIM28 data from K562 
and U2-OS cells. Clustering of these data around SetDB1 
peaks revealed clusters clearly enriched with H3K9me3–
H3K36me2/3 (Fig. 8d, e). These data collectively indicate 
a link between zinc finger–TRIM28–SetDB1 pathway 
and the H3K9me3–H3K36me2/3 bivalent chromatin 
state.
Discussion
In this study, we developed an innovative strategy for a 
combined readout of two histone PTMs in a single-step 
chromatin precipitation using amounts of chromatin 
that are typically needed in conventional ChIP experi-
ments. This is an extension of the technology that applies 
recombinant HiMIDs for readout of single histone 
PTMs in ChIP-like experiments [37, 38]. We showed 
that the recombinant double-HiMIDs robustly perform 
in CIDOP-seq experiments. The recombinant nature of 
these affinity reagents permits for straightforward protein 
engineering enabling the fusion of individual HiMIDs to 
generate a double-HiMID, an approach not possible with 
conventional antibody technology. We show that two 
well-characterized HiMIDs targeted toward H3K9me3 
and H3K36me2/3 after fusion preferentially interact with 
mononucleosomes bearing both modifications. System-
atic repetitions of our CIDOP-qPCR and CIDOP-seq 
experiments confirmed high reproducibility of the data, 
indicating that using appropriate signal thresholds (ide-
ally in combination with single HiMIDs or antibodies 
detecting the individual modifications) double-HiMIDs 
can be used to directly map doubly modified chromatin, 
an experimental challenge that cannot be solved easily 
with existing technologies.
After finishing this work, two alternative approaches 
for the analysis of double chromatin marks were pre-
sented highlighting the importance of this scientific 
question. Weiner et  al. [66] used sequential-ChIP cou-
pled with barcoding, which allowed them to carry out 
genome-wide studies of H3K4me3 and H3K27me3, as 
well as H3K9me1 and H3K27ac. In addition, Shema 
et  al. [67] used single-molecule detection of surface 
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immobilized nucleosomes with different antibodies fol-
lowed by sequencing of the nucleosomal DNA to map 
combinatorial chromatin modifications. However, both 
these methods have their limitations as well. The sequen-
tial-ChIP procedure contains many steps, and like our 
method it depends on careful validation of the results. 
The single-nucleosome approach currently is limited 
by the throughput, and it does not reach genome-wide 
coverage.
In the future, many more combinations of HiMIDs can 
be fused together, validated and applied in studies of other 
bivalent states or co-occurring histone PTMs such as 
H3K4me3 and H3K27me3 or H3K9me3 and H4K20me3. 
The art of the design of double-HiMIDs will be to gener-
ate parts in which isolated HiMIDs would not be able to 
pull-down chromatin under the experimental conditions, 
but only the synergistic interaction of the double-HiMID 
bound to both target marks would be sufficiently strong 
for pull-down. This goal was ideally reached in the case of 
the D3PWWP domain used here, not yet for M8Chromo. 
Additional design cycles may allow to change this and 
further increase the specificity toward doubly modified 
Fig. 7 Association of the H3K9me3–H3K36me2/3 bivalent state with enhancer types. a Composite profiles of H3K9me3–H3K36me2/3, H3K9me3 
and H3K36me2/3 distribution, centered on H3K4me1 peaks associated with the indicated types of enhancers. b, c Clustering analysis of tag 
densities of H3K9me3–H3K36me2/3, H3K9me3, H3K36me2/3 and RNA pol II. Tags were collected in 10-kb windows (− 5 to + 5 kb) centered on 
the midpoints H3K4me1 peaks associated with the chromatin states WE-2 (b) or SE-2 (c) and sorted by k-means clustering (ten clusters). Clusters 
with clear H3K9me3–H3K36me2/3 signal are labeled with red numbers. Other clusters not showing strong H3K9me3–H3K36me2/3 signal are not 
annotated. The image also shows that H3K9me3–H3K36me2/3 signal is only observed at regions with H3K9me3 and H3K36me2/3 signals confirm-
ing AND-readout. d Representative gene ontology (GO) analysis of biological processes linked with cluster 4 from WE-2 and cluster 7 from SE-2. For 
more information about all the other clusters, refer to Additional file 1: Tables S2 and S3
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chromatin. In addition, the PWWP domain of DNMT3A 
and its DNMT3B paralog [68–70] have been shown to 
bind DNA which could influence the pull-down efficiency 
and specificity and needs to be investigated further, for 
example, using PWWP mutants with lost DNA binding 
but intact binding of methylated H3K36. As described in 
the results section, the results with double trimethyllysine 
analog containing peptides suggest that the D3PWWP-
M8Chromo double-HiMID does not interact with single 
histones containing both modifications. This preliminary 
finding points into another important direction of further 
design efforts, because a double-HiMID with cis-binding 
would be of great applicative value.
We used the newly developed affinity reagent to inves-
tigate the localization and distribution of the H3K9me3–
H3K36me2/3 bivalent state on a genome-wide scale. 
We observed a unique distribution of H3K9me3–
H3K36me2/3 doubly modified nucleosomes, which is 
distinct from the distribution of both individual modi-
fications, indicating that the combined deposition of 
both marks did not occur by chance, but the H3K9me3–
H3K36me2/3 signal represents a newly defined bivalent 
chromatin state. So far, the functional relevance of the 
co-occurrence of H3K9me3 and K36me2/3 methyla-
tions has been elucidated in S. pombe only, where it was 
shown that RNAPII transcribes centromeric repeats in 
a brief period during the S-phase. Transcription allows 
for H3K36me2/3 deposition at these sites, which in turn 
contributes to silencing and heterochromatin formation 
in a pathway parallel to the Clr4 pathway, which intro-
duces H3K9me3 [71]. The major insight provided in our 
work is the association of the H3K9me3–H3K36me2/3 
Fig. 8 Association of the H3K9me3–H3K36me2/3 bivalent state with the zinc finger–Trim28–SetDB1 pathway. a Overlap of H3K9me3–H3K36me2/3 
with peaks of DNA-binding factors from the Re-Map database. b Genome browser view of a part of chromosome 19 with many zinc finger (ZNF) 
genes showing co-localization of ZNF274 signal and H3K9me3–H3K36me2/3. D3PWWP-M8Chromo CIDOP-seq data were confirmed by CIDOP-
qPCR using 5 H3K9me3–H3K36me2/3 peak and 2 control regions (Additional file 1: Table S5). The error bars show SEM values based on two 
independent biological repeats. c Clustering analysis of tag densities of H3K9me3–H3K36me2/3 and ZNF274. Tags were collected in 20-kb window 
(− 10 to + 10 kb) centered on the midpoints ZNF274 peaks and sorted by k-means clustering (ten clusters). d Clustering analysis of tag densities of 
SetDB1 and TRIM28 from K652 cells with H3K9me3–H3K36me2/3 from HepG2 cells. Tags were collected in 10-kb windows (− 5 to + 5 kb) centered 
on the midpoints SetDB1 peaks and sorted by k-means clustering (ten clusters). e Clustering analysis of tag densities of SetDB1 and TRIM28 from 
U2-OS cells with H3K9me3–H3K36me2/3 from HepG2 cells. Tags were collected in 10-kb windows (− 5 to + 5 kb) centered on the midpoints 
SetDB1 peaks and sorted by k-means clustering (ten clusters)
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bivalent state with weakly transcribed chromatin states 
such as lowly expressed genes and enhancers. The biva-
lent H3K9me3–H3K36me2/3 state holds the middle 
ground between repression and activation, in accord with 
countless studies, which have reported the association of 
H3K9me3 with repressed chromatin and H3K36me2/3 
with actively transcribed chromatin, due to its deposition 
by the elongating RNAPII. Our results are in agreement 
with previous findings of co-occurrence of H3K9me3 
and H3K36me2/3 in gene bodies with roles in alternative 
splicing [32, 33].
We uncovered that the genes associated with these 
weakly transcribed states in HepG2 cells marked by 
H3K9me3–H3K36me2/3 have a role in cell cycle regu-
lation, metabolism and signaling. We observed a very 
prominent co-localization of H3K9me3–H3K36me2/3 
with ZNF274 and SetDB1 binding sites (albeit using data 
from different cell types), indicating that the SetDB1 
pathway may intersect with the H3K9me3–H3K36me2/3 
chromatin state. In agreement with these findings, 
zinc finger gene 3′ exons which represent one group of 
ZNF274 and SETDB1 binding sites were previously 
shown to contain H3K9me3 and H3K36me2/3 modifica-
tions [35, 36]. Interestingly, Blahnik et al. [35] could not 
find indications for an allelic separation of both marks, 
suggesting that the regions are bivalently marked as sug-
gested by our data as well. Mechanistically, the connec-
tion of the H3K9me3–H3K36me2/3 state to SETDB1 is 
striking, because this enzyme is one of the main factors 
introducing H3K9me3. Further studies should addition-
ally dissect the relationship of the coexistence of the 
bivalent H3K9me3–H3K36me2/3 state and SetDB1 in 
terminally differentiated and embryonic stem cells.
Conclusions
We have introduced the application of double-HiMIDs 
for the direct single-step genome-wide analysis of com-
binatorial chromatin modifications and validated it using 
a double HiMID consisting of the MPP8 chromodomain 
and DNMT3A PWWP domain reading H3K9me3–
H3K36me2/3. The application of this and related double-
HiMIDs has the potential to propel chromatin research 
by allowing holistic studies of co-occurrence and dis-
tribution of many combinations of chromatin marks in 
unprecedented detail. This experimental approach will 
aid the community in providing a novel and very potent 
method to investigate the combinatorial pattern of his-
tone modifications. Our discovery of a novel H3K9me3–
H3K36me2/3 bivalent chromatin state illustrates the 
power of this approach, and it will stimulate numerous 
follow-up studies on its biological functions.
Abbreviations
ChIP: chromatin immunoprecipitation; CIDOP: chromatin interacting domain 
precipitation; GO: gene ontology; HiMID: histone modification interacting 
domain; PKMT: protein lysine methyltransferase; PTM: post-translational modi-
fication; qPCR: quantitative PCR; ZNF: zinc finger.
Authors’ contributions
AJ and GK conceived and designed the experiments. RM performed the 
experiments with contributions from CK and GK. RR contributed to the deep 
sequencing data production. GK analyzed the deep sequencing data. RM, GK 
and AJ were involved in data analysis and interpretation. GK and AJ wrote the 
manuscript draft. All authors read and approved the final manuscript.
Author details
1 Department of Biochemistry, Institute of Biochemistry and Technical 
Biochemistry, Stuttgart University, Allmandring 31, 70569 Stuttgart, Germany. 
2 Max-Planck-Genomzentrum Köln, Carl-von-Linné-Weg 10, 50829 Cologne, 
Germany. 
Acknowledgements
We gratefully acknowledge help of Dr. Daniel Maisch (Intavis AG, Köln) in the 
preparation of double peptide arrays.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The CIDOP-seq raw data have been submitted to the ArrayExpress data-
base (https://www.ebi.ac.uk/arrayexpress/) under the accession number 
E-MTAB-4216. The raw input, MPP8 Chromo and DNMT3A PWWP data were 
taken from [37] and can be found under the accession number E-MTAB-2143. 
All additional data generated or analyzed during this study are included in the 
published article and its Additional files 1, 2 and 3.
Consent for publication
Not applicable.
Ethical approval and consent to participate
Not applicable.
Funding
This work has been supported by the DFG JE 252/26-1. The funder had no role 
in the design of the study and collection, analysis, and interpretation of data 
and in writing the manuscript.
Additional files
Additional file 1: Figure S1. Analysis of the coexistence of H3K9me3 
and H3K36me2/3 in one H3 molecule by mass spectrometry. Figure S2. 
Control experiments related to Fig. 2. Figure S3. Quality control of double 
peptide spot arrays. Figure S4. Definition of chromatin states in HepG2 
cells based on H3K9me3 and H3K36me2/3 CIDOP-seq signals using 1 kb 
bins. Figure S5. Definition of chromatin states based on Ernst et al. 2011. 
Figure S6. Annotated sequence of the D3PWWP-M8Chromo double 
domain. Table S1. GO analysis of low expression gene clusters shown 
in Fig. 6c. Table S2. GO analysis of the clusters of genes regulated by 
weak enhancers-2 shown in Fig. 7b. Table S3. GO analysis of the clusters 
of genes regulated by strong enhancers-2 shown in Fig. 7c. Table S4. 
Sequences of primers used in Fig. 5 for CIDOP-qPCR. Table S5. Sequences 
of primers used in Fig. 8b for CIDOP-qPCR.
Additional file 2: Table S6. Full annotation of the peptides present on 
the CelluSpots modified histone tail peptide array.
Additional file 3. Interaction of the D3PWWP-M8Chromo double-HiMID 
with double modified H3-GST peptides.
Page 18 of 19Mauser et al. Epigenetics & Chromatin  (2017) 10:45 
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
Received: 10 August 2017   Accepted: 18 September 2017
References
 1. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifica-
tions. Cell Res. 2011;21:381–95.
 2. Tan M, Luo H, Lee S, Jin F, Yang JS, Montellier E, Buchou T, Cheng Z, 
Rousseaux S, Rajagopal N, et al. Identification of 67 histone marks and 
histone lysine crotonylation as a new type of histone modification. Cell. 
2011;146:1016–28.
 3. Portela A, Esteller M. Epigenetic modifications and human disease. Nat 
Biotechnol. 2010;28:1057–68.
 4. Suganuma T, Workman JL. Signals and combinatorial functions of histone 
modifications. Annu Rev Biochem. 2011;80:473–99.
 5. Suva ML, Riggi N, Bernstein BE. Epigenetic reprogramming in cancer. Sci-
ence. 2013;339:1567–70.
 6. Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. How chromatin-bind-
ing modules interpret histone modifications: lessons from professional 
pocket pickers. Nat Struct Mol Biol. 2007;14:1025–40.
 7. Patel DJ, Wang Z. Readout of epigenetic modifications. Annu Rev Bio-
chem. 2013;82:81–118.
 8. Strahl BD, Allis CD. The language of covalent histone modifications. 
Nature. 2000;403:41–5.
 9. Jenuwein T, Allis CD. Translating the histone code. Science. 
2001;293:1074–80.
 10. Cieslik M, Bekiranov S. Combinatorial epigenetic patterns as quantitative 
predictors of chromatin biology. BMC Genom. 2014;15:76.
 11. Ruthenburg AJ, Li H, Patel DJ, Allis CD. Multivalent engagement of chro-
matin modifications by linked binding modules. Nat Rev Mol Cell Biol. 
2007;8:983–94.
 12. Musselman CA, Lalonde ME, Cote J, Kutateladze TG. Perceiving the 
epigenetic landscape through histone readers. Nat Struct Mol Biol. 
2012;19:1218–27.
 13. Su Z, Denu JM. Reading the combinatorial histone language. ACS Chem 
Biol. 2016;11:564–74.
 14. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K, 
Roh TY, Peng W, Zhang MQ, Zhao K. Combinatorial patterns of histone 
acetylations and methylations in the human genome. Nat Genet. 
2008;40:897–903.
 15. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, 
Zhang X, Wang L, Issner R, Coyne M, et al. Mapping and analysis of chro-
matin state dynamics in nine human cell types. Nature. 2011;473:43–9.
 16. Vastenhouw NL, Schier AF. Bivalent histone modifications in early 
embryogenesis. Curr Opin Cell Biol. 2012;24:374–86.
 17. Voigt P, Tee WW, Reinberg D. A double take on bivalent promoters. Genes 
Dev. 2013;27:1318–38.
 18. Soloway PD. Analysis of combinatorial epigenomic states. ACS Chem Biol. 
2016;11:621–31.
 19. Young NL, Dimaggio PA, Garcia BA. The significance, development and 
progress of high-throughput combinatorial histone code analysis. Cell 
Mol Life Sci. 2010;67:3983–4000.
 20. Martin C, Zhang Y. The diverse functions of histone lysine methylation. 
Nat Rev Mol Cell Biol. 2005;6:838–49.
 21. Krishnan S, Horowitz S, Trievel RC. Structure and function of histone 
H3 lysine 9 methyltransferases and demethylases. ChemBioChem. 
2011;12:254–63.
 22. Becker JS, Nicetto D, Zaret KS. H3K9me3-dependent heterochromatin: 
barrier to cell fate changes. Trends Genet. 2016;32:29–41.
 23. Mozzetta C, Boyarchuk E, Pontis J, Ait-Si-Ali S. Sound of silence: the prop-
erties and functions of repressive Lys methyltransferases. Nat Rev Mol Cell 
Biol. 2015;16:499–513.
 24. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, 
Chepelev I, Zhao K. High-resolution profiling of histone methylations in 
the human genome. Cell. 2007;129:823–37.
 25. Wagner EJ, Carpenter PB. Understanding the language of Lys36 methyla-
tion at histone H3. Nat Rev Mol Cell Biol. 2012;13:115–26.
 26. Carrozza MJ, Li B, Florens L, Suganuma T, Swanson SK, Lee KK, Shia WJ, 
Anderson S, Yates J, Washburn MP, Workman JL. Histone H3 methylation 
by Set2 directs deacetylation of coding regions by Rpd3S to suppress 
spurious intragenic transcription. Cell. 2005;123:581–92.
 27. Keogh MC, Kurdistani SK, Morris SA, Ahn SH, Podolny V, Collins SR, 
Schuldiner M, Chin K, Punna T, Thompson NJ, et al. Cotranscriptional set2 
methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. 
Cell. 2005;123:593–605.
 28. Bartke T, Vermeulen M, Xhemalce B, Robson SC, Mann M, Kouzarides T. 
Nucleosome-interacting proteins regulated by DNA and histone meth-
ylation. Cell. 2010;143:470–84.
 29. Smolle M, Venkatesh S, Gogol MM, Li H, Zhang Y, Florens L, Washburn MP, 
Workman JL. Chromatin remodelers Isw1 and Chd1 maintain chromatin 
structure during transcription by preventing histone exchange. Nat 
Struct Mol Biol. 2012;19:884–92.
 30. Dhayalan A, Rajavelu A, Rathert P, Tamas R, Jurkowska RZ, Ragozin S, 
Jeltsch A. The Dnmt3a PWWP domain reads histone 3 lysine 36 trimeth-
ylation and guides DNA methylation. J Biol Chem. 2010;285:26114–20.
 31. Baubec T, Colombo DF, Wirbelauer C, Schmidt J, Burger L, Krebs AR, Akalin 
A, Schubeler D. Genomic profiling of DNA methyltransferases reveals a 
role for DNMT3B in genic methylation. Nature. 2015;520:243–7.
 32. Kolasinska-Zwierz P, Down T, Latorre I, Liu T, Liu XS, Ahringer J. Differential 
chromatin marking of introns and expressed exons by H3K36me3. Nat 
Genet. 2009;41:376–81.
 33. Saint-Andre V, Batsche E, Rachez C, Muchardt C. Histone H3 lysine 9 
trimethylation and HP1gamma favor inclusion of alternative exons. Nat 
Struct Mol Biol. 2011;18:337–44.
 34. Young NL, DiMaggio PA, Plazas-Mayorca MD, Baliban RC, Floudas CA, 
Garcia BA. High throughput characterization of combinatorial histone 
codes. Mol Cell Proteomics. 2009;8:2266–84.
 35. Blahnik KR, Dou L, Echipare L, Iyengar S, O’Geen H, Sanchez E, Zhao Y, 
Marra MA, Hirst M, Costello JF, et al. Characterization of the contradictory 
chromatin signatures at the 3′ exons of zinc finger genes. PLoS ONE. 
2011;6:e17121.
 36. Valle-Garcia D, Qadeer ZA, McHugh DS, Ghiraldini FG, Chowdhury AH, 
Hasson D, Dyer MA, Recillas-Targa F, Bernstein E. ATRX binds to atypical 
chromatin domains at the 3′ exons of zinc finger genes to preserve 
H3K9me3 enrichment. Epigenetics. 2016;11:398–414.
 37. Kungulovski G, Kycia I, Tamas R, Jurkowska RZ, Kudithipudi S, Henry C, 
Reinhardt R, Labhart P, Jeltsch A. Application of histone modification-
specific interaction domains as an alternative to antibodies. Genome Res. 
2014;24:1842–53.
 38. Kungulovski G, Mauser R, Reinhardt R, Jeltsch A. Application of recombi-
nant TAF3 PHD domain instead of anti-H3K4me3 antibody. Epigenetics 
Chromatin. 2016;9:11.
 39. Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA 3rd, Smith HO. 
Enzymatic assembly of DNA molecules up to several hundred kilobases. 
Nat Methods. 2009;6:343–5.
 40. Rathert P, Dhayalan A, Murakami M, Zhang X, Tamas R, Jurkowska R, 
Komatsu Y, Shinkai Y, Cheng X, Jeltsch A. Protein lysine methyltransferase 
G9a acts on non-histone targets. Nat Chem Biol. 2008;4:344–6.
 41. Jeltsch A, Lanio T. Site-directed mutagenesis by polymerase chain reac-
tion. Methods Mol Biol. 2002;182:85–94.
 42. Shechter D, Dormann HL, Allis CD, Hake SB. Extraction, purification and 
analysis of histones. Nat Protoc. 2007;2:1445–57.
 43. Bock I, Dhayalan A, Kudithipudi S, Brandt O, Rathert P, Jeltsch A. Detailed 
specificity analysis of antibodies binding to modified histone tails with 
peptide arrays. Epigenetics. 2011;6:256–63.
 44. Maisch D, Schmitz I, Brandt O. CelluSpots arrays as an alternative to pep-
tide arrays on membrane supports. Mini-Rev Org Chem. 2011;8:132–6.
 45. Dikmans A, Beutling U, Schmeisser E, Thiele S, Frank R. SC2: A novel pro-
cess for manufacturing multipurpose high-density chemical microarrays. 
QSAR Comb Sci. 2006;25:1069–80.
 46. Kasinathan S, Orsi GA, Zentner GE, Ahmad K, Henikoff S. High-resolution 
mapping of transcription factor binding sites on native chromatin. Nat 
Methods. 2014;11:203–9.
 47. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-
efficient alignment of short DNA sequences to the human genome. 
Genome Biol. 2009;10:R25.
Page 19 of 19Mauser et al. Epigenetics & Chromatin  (2017) 10:45 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 48. Kallio MA, Tuimala JT, Hupponen T, Klemela P, Gentile M, Scheinin I, Koski 
M, Kaki J, Korpelainen EI. Chipster: user-friendly analysis software for 
microarray and other high-throughput data. BMC Genom. 2011;12:507.
 49. Goecks J, Nekrutenko A, Taylor J. Galaxy: a comprehensive approach for 
supporting accessible, reproducible, and transparent computational 
research in the life sciences. Genome Biol. 2010;11:R86.
 50. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, 
Nusbaum C, Myers RM, Brown M, Li W, Liu XS. Model-based analysis of 
ChIP-Seq (MACS). Genome Biol. 2008;9:R137.
 51. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing 
genomic features. Bioinformatics. 2010;26:841–2.
 52. Ramirez F, Dundar F, Diehl S, Gruning BA, Manke T. deepTools: a flex-
ible platform for exploring deep-sequencing data. Nucleic Acids Res. 
2014;42:W187–91.
 53. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz 
G, Mesirov JP. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–6.
 54. Halachev K, Bast H, Albrecht F, Lengauer T, Bock C. EpiExplorer: live explo-
ration and global analysis of large epigenomic datasets. Genome Biol. 
2012;13:R96.
 55. Ye T, Krebs AR, Choukrallah MA, Keime C, Plewniak F, Davidson I, Tora L. 
seqMINER: an integrated ChIP-seq data interpretation platform. Nucleic 
Acids Res. 2011;39:e35.
 56. Welch RP, Lee C, Imbriano PM, Patil S, Weymouth TE, Smith RA, Scott LJ, 
Sartor MA. ChIP-Enrich: gene set enrichment testing for ChIP-seq data. 
Nucleic Acids Res. 2014;42:e105.
 57. ENCODE-Consortium. An integrated encyclopedia of DNA elements in 
the human genome. Nature. 2012;489:57–74.
 58. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, 
Haussler D. The human genome browser at UCSC. Genome Res. 
2002;12:996–1006.
 59. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, 
Salzberg SL, Rinn JL, Pachter L. Differential gene and transcript expression 
analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 
2012;7:562–78.
 60. Ruthenburg AJ, Li H, Milne TA, Dewell S, McGinty RK, Yuen M, Ueberheide 
B, Dou Y, Muir TW, Patel DJ, Allis CD. Recognition of a mononucleosomal 
histone modification pattern by BPTF via multivalent interactions. Cell. 
2011;145:692–706.
 61. Bock I, Kudithipudi S, Tamas R, Kungulovski G, Dhayalan A, Jeltsch A. 
Application of Celluspots peptide arrays for the analysis of the binding 
specificity of epigenetic reading domains to modified histone tails. BMC 
Biochem. 2011;12:48.
 62. Chang Y, Horton JR, Bedford MT, Zhang X, Cheng X. Structural insights 
for MPP8 chromodomain interaction with histone H3 lysine 9: poten-
tial effect of phosphorylation on methyl-lysine binding. J Mol Biol. 
2011;408:807–14.
 63. Simon MD, Chu F, Racki LR, de la Cruz CC, Burlingame AL, Panning B, Nar-
likar GJ, Shokat KM. The site-specific installation of methyl-lysine analogs 
into recombinant histones. Cell. 2007;128:1003–12.
 64. Zentner GE, Tesar PJ, Scacheri PC. Epigenetic signatures distinguish mul-
tiple classes of enhancers with distinct cellular functions. Genome Res. 
2011;21:1273–83.
 65. Griffon A, Barbier Q, Dalino J, van Helden J, Spicuglia S, Ballester B. 
Integrative analysis of public ChIP-seq experiments reveals a complex 
multi-cell regulatory landscape. Nucleic Acids Res. 2015;43:e27.
 66. Weiner A, Lara-Astiaso D, Krupalnik V, Gafni O, David E, Winter DR, 
Hanna JH, Amit I. Co-ChIP enables genome-wide mapping of histone 
mark co-occurrence at single-molecule resolution. Nat Biotechnol. 
2016;34:953–61.
 67. Shema E, Jones D, Shoresh N, Donohue L, Ram O, Bernstein BE. Single-
molecule decoding of combinatorially modified nucleosomes. Science. 
2016;352:717–21.
 68. Qiu C, Sawada K, Zhang X, Cheng X. The PWWP domain of mammalian 
DNA methyltransferase Dnmt3b defines a new family of DNA-binding 
folds. Nat Struct Biol. 2002;9:217–24.
 69. Purdy MM, Holz-Schietinger C, Reich NO. Identification of a second DNA 
binding site in human DNA methyltransferase 3A by substrate inhibition 
and domain deletion. Arch Biochem Biophys. 2010;498:13–22.
 70. Rondelet G, Dal Maso T, Willems L, Wouters J. Structural basis for recogni-
tion of histone H3K36me3 nucleosome by human de novo DNA methyl-
transferases 3A and 3B. J Struct Biol. 2016;194:357–67.
 71. Chen ES, Zhang K, Nicolas E, Cam HP, Zofall M, Grewal SI. Cell cycle con-
trol of centromeric repeat transcription and heterochromatin assembly. 
Nature. 2008;451:734–7.
